RÉSUMÉ
The liver is vulnerable to various hepatotoxins, including carbon tetrachloride (CCl4), which induces oxidative stress and apoptosis by producing reactive oxygen species (ROS) and activating the mitogen-activated protein kinase (MAPK) pathway. Cereblon (CRBN), a multifunctional protein implicated in various cellular processes, functions in the pathogenesis of various diseases; however, its function in liver injury remains unknown. We established a CRBN-knockout (KO) HepG2 cell line and examined its effect on CCl4-induced hepatocellular damage. CRBN-KO cells exhibited reduced sensitivity to CCl4-induced cytotoxicity, as evidenced by decreased levels of apoptosis markers, such as cleaved caspase-3, and aspartate aminotransferase (AST) and alanine aminotransferase (ALT) activities. CRBN deficiency enhanced antioxidant defense, with increased superoxide dismutase activity and glutathione ratios (GSH/GSSG), as well as reduced pro-inflammatory cytokine expression. Mechanistically, the protective effects of CRBN deficiency appeared to involve the attenuation of the MAPK-mediated pathways, particularly through decreased phosphorylation of JNK and ERK. Overall, these results suggest the crucial role of CRBN in mediating the hepatocellular response to oxidative stress and inflammation triggered by CCl4 exposure, offering potential clinical implications for liver injury in a wide range of liver diseases.
Sujet(s)
Protéines adaptatrices de la transduction du signal , Apoptose , Tétrachloro-méthane , Lésions hépatiques dues aux substances , Stress oxydatif , Humains , Apoptose/effets des médicaments et des substances chimiques , Cellules HepG2 , Tétrachloro-méthane/toxicité , Lésions hépatiques dues aux substances/métabolisme , Lésions hépatiques dues aux substances/étiologie , Protéines adaptatrices de la transduction du signal/métabolisme , Protéines adaptatrices de la transduction du signal/génétique , Stress oxydatif/effets des médicaments et des substances chimiques , Ubiquitin-protein ligases/métabolisme , Ubiquitin-protein ligases/génétique , Ubiquitin-protein ligases/déficit , Système de signalisation des MAP kinases/effets des médicaments et des substances chimiques , Mitogen-Activated Protein Kinases/métabolisme , Espèces réactives de l'oxygène/métabolismeRÉSUMÉ
IL-33 belongs to the inflammatory factor family and is closely associated with the inflammatory response. However, its role in the development of intrauterine adhesions (IUAs) remains unclear. In this study, the role of IL-33 in the formation of IUAs after endometrial injury was identified via RNA sequencing after mouse endometrial organoids were transplanted into an IUA mouse model. Major pathological changes in the mouse uterus, consistent with the expression of fibrotic markers, such as TGF-ß, were observed in response to treatment with IL-33. This finding may be attributed to activation of the phosphorylation of downstream MAPK signaling pathway components, which are activated by the release of IL-33 in macrophages. Our study provides a novel mechanism for elucidating IUA formation, suggesting a new therapeutic strategy for the prevention and clinical treatment of IUAs.
Sujet(s)
Interleukine-33 , Système de signalisation des MAP kinases , Animaux , Interleukine-33/métabolisme , Interleukine-33/génétique , Femelle , Souris , Adhérences tissulaires/métabolisme , Adhérences tissulaires/anatomopathologie , Maladies de l'utérus/anatomopathologie , Maladies de l'utérus/métabolisme , Maladies de l'utérus/génétique , Souris de lignée C57BL , Modèles animaux de maladie humaine , Transduction du signal , Utérus/métabolisme , Utérus/anatomopathologie , Endomètre/métabolisme , Endomètre/anatomopathologie , Mitogen-Activated Protein Kinases/métabolisme , Mitogen-Activated Protein Kinases/génétiqueRÉSUMÉ
This study aimed to investigate the protective effect and its underlying mechanism of n-butanol extract of Pulsatilla Decoction(BEPD) containing medicinal serum on vaginal epithelial cells under Candida glabrata stimulation via the epidermal growth factor receptor/mitogen activated protein kinase( EGFR/MAPK) pathway based on transcriptomics. A vulvovaginal candidiasis(VVC) mouse model was established first and transcriptome sequencing was performed for the vaginal mucosa tissues to analyze the gene expression differences among the control, VVC model, and BEPD intervention groups. Simultaneously, BEPD-containing serum and fluconazole-containing serum were prepared. A431 cells were divided into the control, model, blank serum, fluconazole-containing serum, BEPD-containing serum, EGFR agonist and EGFR inhibitor groups. Additionally, in vitro experiments were conducted using BEPD-containing serum, fluconazole-containing serum, and an EGFR agonist and inhibitor to investigate the intervention mechanisms of BEPD on C. glabrata-induced vaginal epithelial cell damage. Cell counting kit-8(CCK-8) assay was utilized to determine the safe concentrations of C. glabrata, drug-containing serum, and compounds on A431 cells. Enzyme-linked immunosorbent assay(ELISA)was employed to measure the expression levels of interleukin(IL)-1ß, IL-6, granulocyte-macrophage colony-stimulating factor(GMCSF), granulocyte CSF(G-CSF), chemokine(C-X-C motif) ligand 20(CCL20), and lactate dehydrogenase(LDH). Gram staining was used to evaluate the adhesion of C. glabrata to vaginal epithelial cells. Flow cytometry was utilized to assess the effect of C.glabrata on A431 cell apoptosis. Based on the transcriptomics results, immunofluorescence was performed to measure the expressions of p-EGFR and p-ERK1/2 proteins, while Western blot validated the expressions of p-EGFR, p-ERK1/2, p-C-Fos, p-P38, Bax and Bcl-2 proteins. Sequencing results showed that compared with the VVC model, BEPD treatment up-regulated 1 075 genes and downregulated 927 genes, mainly enriched in immune-inflammatory pathways, including MAPK. Mechanistically, BEPD significantly reduced the expression of p-EGFR, p-ERK1/2, p-C-Fos and p-P38, as well as the secretion of IL-1ß, IL-6, GM-CSF, G-CSF and CCL20, LDH release induced by C. glabrata, and the adhesion of C. glabrata to A431 cells, suggesting that BEPD exerts a protective effect on vaginal epithelial cells damaged by C. glabrata infection by modulating the EGFR/MAPK axis. In addition, BEPD downregulated the pro-apoptotic protein Bax expression and up-regulated the anti-apoptotic protein Bcl-2 expression, leading to a reduction in C. glabrata-induced cell apoptosis. In conclusion, this study reveals that the intervention of BEPD in C. glabrata-induced VVC may be attributed to its regulation of the EGFR/MAPK pathway, which protects vaginal epithelial cells.
Sujet(s)
Candida albicans , Cellules épithéliales , Récepteurs ErbB , Pulsatilla , Vagin , Femelle , Récepteurs ErbB/génétique , Récepteurs ErbB/métabolisme , Cellules épithéliales/effets des médicaments et des substances chimiques , Cellules épithéliales/métabolisme , Vagin/microbiologie , Vagin/effets des médicaments et des substances chimiques , Candida albicans/effets des médicaments et des substances chimiques , Souris , Humains , Animaux , Pulsatilla/composition chimique , Transcriptome/effets des médicaments et des substances chimiques , Butan-1-ol/composition chimique , Médicaments issus de plantes chinoises/pharmacologie , Système de signalisation des MAP kinases/effets des médicaments et des substances chimiques , Candidose vulvovaginale/traitement médicamenteux , Candidose vulvovaginale/microbiologie , Agents protecteurs/pharmacologie , Agents protecteurs/composition chimique , Mitogen-Activated Protein Kinases/métabolisme , Mitogen-Activated Protein Kinases/génétique , Candida glabrata/effets des médicaments et des substances chimiques , Candida glabrata/génétiqueRÉSUMÉ
Polysaccharide is one of the principal bioactive components found in medicinal mushrooms and has been proven to enhance host immunity. However, the possible mechanism of immunomodulatory activity of Cordyceps militaris polysaccharide is not fully understood. Hot water extraction and alcohol precipitation, DEAE-Sephadex A-25 chromatography, and Sephadex G-100 chromatography were used to isolate polysaccharide from C. militaris. A high-molecular-weight polysaccharide isolated from C. militaris was designated as HCMP, which had an Mw of 6.18 × 105 Da and was composed of arabinose, galactose, glucose, mannose, and xylose in a mole ratio of 2.00:8.01:72.54:15.98:1.02. The polysaccharide content of HCMP was 91.2% ± 0.16. The test in vitro showed that HCMP activated mouse macrophage RAW 264.7 cells by enhancing phagocytosis and NO production, and by regulating mRNA expressions of inflammation-related molecules in RAW 264.7 cells. Western blotting revealed that HCMP induced the phosphorylation of mitogen-activated protein kinases (MAPKs). Moreover, using inhibitors of MAPKs decreased the mRNA levels of inflammation-related molecules induced by HCMP. These data evidenced that the immunomodulatory effect of HCMP on RAW 264.7 macrophages was mediated via the MAPK signaling pathway. These findings suggested that HCMP could be developed as a potent immunomodulatory agent for use in functional foods and dietary supplements.
Sujet(s)
Cordyceps , Système de signalisation des MAP kinases , Macrophages , Phagocytose , Animaux , Souris , Cordyceps/composition chimique , Cellules RAW 264.7 , Système de signalisation des MAP kinases/effets des médicaments et des substances chimiques , Macrophages/effets des médicaments et des substances chimiques , Macrophages/métabolisme , Phagocytose/effets des médicaments et des substances chimiques , Polyosides/pharmacologie , Polyosides/composition chimique , Polyosides/isolement et purification , Facteurs immunologiques/pharmacologie , Facteurs immunologiques/composition chimique , Facteurs immunologiques/isolement et purification , Polysaccharides fongiques/pharmacologie , Polysaccharides fongiques/composition chimique , Polysaccharides fongiques/isolement et purification , Monoxyde d'azote/métabolisme , Mitogen-Activated Protein Kinases/métabolismeRÉSUMÉ
The cell wall is the first barrier against external adversity and plays roles in maintaining normal physiological functions of fungi. Previously, we reported a nucleosome assembly protein, MoNap1, in Magnaporthe oryzae that plays a role in cell wall integrity (CWI), stress response, and pathogenicity. Moreover, MoNap1 negatively regulates the expression of MoSMI1 encoded by MGG_03970. Here, we demonstrated that deletion of MoSMI1 resulted in a significant defect in appressorium function, CWI, cell morphology, and pathogenicity. Further investigation revealed that MoSmi1 interacted with MoOsm1 and MoMps1 and affected the phosphorylation levels of MoOsm1, MoMps1, and MoPmk1, suggesting that MoSmi1 regulates biological functions by mediating mitogen-activated protein kinase (MAPK) signalling pathway in M. oryzae. In addition, transcriptome data revealed that MoSmi1 regulates many infection-related processes in M. oryzae, such as membrane-related pathway and oxidation reduction process. In conclusion, our study demonstrated that MoSmi1 regulates CWI by mediating the MAPK pathway to affect development and pathogenicity of M. oryzae.
Sujet(s)
Protéines fongiques , Mitogen-Activated Protein Kinases , Protéines fongiques/métabolisme , Protéines fongiques/génétique , Mitogen-Activated Protein Kinases/métabolisme , Mitogen-Activated Protein Kinases/génétique , Virulence/génétique , Régulation de l'expression des gènes fongiques , Maladies des plantes/microbiologie , Paroi cellulaire/métabolisme , Système de signalisation des MAP kinases , Oryza/microbiologie , Phosphorylation , Magnaporthe/pathogénicité , Magnaporthe/génétique , AscomycotaRÉSUMÉ
Peptostreptococcus stomatis (P. stomatis) is enriched in colorectal cancer (CRC), but its causality and translational implications in CRC are unknown. Here, we show that P. stomatis accelerates colonic tumorigenesis in ApcMin/+ and azoxymethane/dextran sodium sulfate (AOM-DSS) models by inducing cell proliferation, suppressing apoptosis, and impairing gut barrier function. P. stomatis adheres to CRC cells through its surface protein fructose-1,6-bisphosphate aldolase (FBA) that binds to the integrin α6/ß4 receptor on CRC cells, leading to the activation of ERBB2 and the downstream MEK-ERK-p90 cascade. Blockade of the FBA-integrin α6/ß4 abolishes ERBB2-mitogen-activated protein kinase (MAPK) activation and the protumorigenic effect of P. stomatis. P. stomatis-driven ERBB2 activation bypasses receptor tyrosine kinase (RTK) blockade by EGFR inhibitors (cetuximab, erlotinib), leading to drug resistance in xenograft and spontaneous CRC models of KRAS-wild-type CRC. P. stomatis also abrogates BRAF inhibitor (vemurafenib) efficacy in BRAFV600E-mutant CRC xenografts. Thus, we identify P. stomatis as an oncogenic bacterium and a contributory factor for non-responsiveness to RTK inhibitors in CRC.
Sujet(s)
Carcinogenèse , Tumeurs colorectales , Résistance aux médicaments antinéoplasiques , Peptostreptococcus , Récepteur ErbB-2 , Animaux , Humains , Souris , Apoptose/effets des médicaments et des substances chimiques , Lignée cellulaire tumorale , Prolifération cellulaire/effets des médicaments et des substances chimiques , Tumeurs colorectales/traitement médicamenteux , Tumeurs colorectales/microbiologie , Tumeurs colorectales/anatomopathologie , Fructose bisphosphate aldolase/métabolisme , Fructose bisphosphate aldolase/génétique , Système de signalisation des MAP kinases/effets des médicaments et des substances chimiques , Mitogen-Activated Protein Kinases/métabolisme , Mitogen-Activated Protein Kinases/génétique , Récepteur ErbB-2/métabolisme , Récepteur ErbB-2/génétique , /pharmacologieRÉSUMÉ
The MAPK signaling pathway with BRAF mutations has been shown to drive the pathogenesis of 40-60% of melanomas. Inhibitors of this pathway's BRAF and MEK components are currently used to treat these malignancies. However, responses to these treatments are not always successful. Therefore, identifying noninvasive biomarkers to predict treatment responses is essential for personalized medicine in melanoma. Using noninvasive 1H magnetic resonance spectroscopy (1H MRS), we previously showed that BRAF inhibition reduces lactate and alanine tumor levels in the early stages of effective therapy and could be considered as metabolic imaging biomarkers for drug response. The present work demonstrates that these metabolic changes observed by 1H MRS and those assessed by 31P MRS are also found in preclinical human melanoma models treated with MEK inhibitors. Apart from 1H and 31P MRS, additional supporting in vitro biochemical analyses are described. Our results indicate significant early metabolic correlations with response levels to MEK inhibition in the melanoma models and are consistent with our previous study of BRAF inhibition. Given these results, our study supports the potential clinical utility of noninvasive MRS to objectively image metabolic biomarkers for the early prediction of melanoma's response to MEK inhibition.
Sujet(s)
Mélanome , Métabolomique , Inhibiteurs de protéines kinases , Mélanome/métabolisme , Mélanome/traitement médicamenteux , Mélanome/anatomopathologie , Humains , Métabolomique/méthodes , Lignée cellulaire tumorale , Inhibiteurs de protéines kinases/pharmacologie , Inhibiteurs de protéines kinases/usage thérapeutique , Protéines proto-oncogènes B-raf/métabolisme , Protéines proto-oncogènes B-raf/antagonistes et inhibiteurs , Spectroscopie par résonance magnétique/méthodes , Mitogen-Activated Protein Kinases/métabolisme , Mitogen-Activated Protein Kinases/antagonistes et inhibiteurs , Spectroscopie par résonance magnétique du proton/méthodesRÉSUMÉ
The DNA damage response (DDR) network and the mitogen-activated protein kinase (MAPK) signaling pathway are crucial mechanisms for the survival of all living beings. An accumulating body of evidence suggests that there is crosstalk between these two systems, thus favoring the appropriate functioning of multi-cellular organisms. On the other hand, aberrations within these mechanisms are thought to play a vital role in the onset and progression of several diseases, including cancer, as well as in the emergence of drug resistance. Here, we provide an overview of the current knowledge regarding alterations in the DDR machinery and the MAPK signaling pathway as well as abnormalities in the DDR/MAPK functional crosstalk in multiple myeloma, the second most common hematologic malignancy. We also present the latest advances in the development of anti-myeloma drugs targeting crucial DDR- and MAPK-associated molecular components. These data could potentially be exploited to discover new therapeutic targets and effective biomarkers as well as for the design of novel clinical trials. Interestingly, they might provide a new approach to increase the efficacy of anti-myeloma therapy by combining drugs targeting the DDR network and the MAPK signaling pathway.
Sujet(s)
Altération de l'ADN , Système de signalisation des MAP kinases , Myélome multiple , Myélome multiple/génétique , Myélome multiple/métabolisme , Myélome multiple/anatomopathologie , Humains , Réparation de l'ADN , Mitogen-Activated Protein Kinases/métabolisme , Antinéoplasiques/usage thérapeutique , Antinéoplasiques/pharmacologie , AnimauxRÉSUMÉ
KEY MESSAGE: Volatile compounds released from basil prime the tomato wound response by promoting jasmonic acid, mitogen-activated protein kinase, and reactive oxygen species signaling. Within mixed planting systems, companion plants can promote growth or enhance stress responses in target plants. However, the mechanisms underlying these effects remain poorly understood. To gain insight into the molecular nature of the effects of companion plants, we investigated the effects of basil plants (Ocimum basilicum var. minimum) on the wound response in tomato plants (Solanum lycopersicum cv. 'Micro-Tom') within a mixed planting system under environmentally controlled chamber. The results showed that the expression of Pin2, which specifically responds to mechanical wounding, was induced more rapidly and more strongly in the leaves of tomato plants cultivated with companion basil plants. This wound response priming effect was replicated through the exposure of tomato plants to an essential oil (EO) prepared from basil leaves. Tomato leaves pre-exposed to basil EO showed enhanced expression of genes related to jasmonic acid, mitogen-activated protein kinase (MAPK), and reactive oxygen species (ROS) signaling after wounding stress. Basil EO also enhanced ROS accumulation in wounded tomato leaves. The wound response priming effect of basil EO was confirmed in wounded Arabidopsis plants. Loss-of-function analysis of target genes revealed that MAPK genes play pivotal roles in controlling the observed priming effects. Spodoptera litura larvae-fed tomato leaves pre-exposed to basil EO showed reduced growth compared with larvae-fed control leaves. Thus, mixed planting with basil may enhance defense priming in both tomato and Arabidopsis plants through the activation of volatile signaling.
Sujet(s)
Cyclopentanes , Régulation de l'expression des gènes végétaux , Ocimum basilicum , Oxylipines , Feuilles de plante , Espèces réactives de l'oxygène , Transduction du signal , Solanum lycopersicum , Solanum lycopersicum/génétique , Solanum lycopersicum/métabolisme , Cyclopentanes/métabolisme , Oxylipines/métabolisme , Espèces réactives de l'oxygène/métabolisme , Régulation de l'expression des gènes végétaux/effets des médicaments et des substances chimiques , Feuilles de plante/génétique , Feuilles de plante/métabolisme , Ocimum basilicum/génétique , Composés organiques volatils/métabolisme , Composés organiques volatils/pharmacologie , Animaux , Huile essentielle/métabolisme , Huile essentielle/pharmacologie , Spodoptera/physiologie , Mitogen-Activated Protein Kinases/métabolisme , Mitogen-Activated Protein Kinases/génétique , Protéines végétales/métabolisme , Protéines végétales/génétiqueRÉSUMÉ
The timing of seed germination is controlled by the combination of internal dormancy and external factors. Temperature is a major environmental factor for seed germination. The permissive temperature range for germination is narrow in dormant seeds and expands during after-ripening (AR) (dormancy release). Quantitative trait loci analyses of preharvest sprouting in cereals have revealed that MKK3, a mitogen-activated protein kinase (MAPK) cascade protein, is a negative regulator of grain dormancy. Here, we show that the MAPKKK19/20-MKK3-MPK1/2/7/14 cascade modulates the germination temperature range in Arabidopsis seeds by elevating the germinability of the seeds at sub- and supraoptimal temperatures. The expression of MAPKKK19 and MAPKKK20 is induced around optimal temperature for germination in after-ripened seeds but repressed in dormant seeds. MPK7 activation depends on the expression levels of MAPKKK19/20, with expression occurring under conditions permissive for germination. Abscisic acid (ABA) and gibberellin (GA) are two major phytohormones which are involved in germination control. Activation of the MKK3 cascade represses ABA biosynthesis enzyme gene expression and induces expression of ABA catabolic enzyme and GA biosynthesis enzyme genes, resulting in expansion of the germinable temperature range. Our data demonstrate that the MKK3 cascade integrates temperature and AR signals to phytohormone metabolism and seed germination.
Sujet(s)
Protéines d'Arabidopsis , Arabidopsis , Régulation de l'expression des gènes végétaux , Germination , Graines , Arabidopsis/génétique , Arabidopsis/métabolisme , Arabidopsis/croissance et développement , Protéines d'Arabidopsis/métabolisme , Protéines d'Arabidopsis/génétique , MAP Kinase Kinase 3/métabolisme , MAP Kinase Kinase 3/génétique , Système de signalisation des MAP kinases/physiologie , Mitogen-Activated Protein Kinases/métabolisme , Mitogen-Activated Protein Kinases/génétique , Dormance des plantes/génétique , Dormance des plantes/physiologie , Graines/croissance et développement , Graines/métabolisme , Graines/génétique , Transduction du signal , TempératureRÉSUMÉ
This study aimed to determine the immunostimulatory activities of ulvan type polysaccharides isolated from Ulva pertusa. First, U. pertusa polysaccharide (UPP) mainly consists of rhamnose, glucuronic acid, iduronic acid, and xylose, which are typical ulvan type monosaccharides. UPP induced phosphorylation of the mitogen-activated protein kinase and nuclear factor-kappa B pathways in macrophages, subsequently triggering cytokine release and phagocytosis. The effects were closely associated with pattern recognition receptors such as dectin-1, mannose receptor, CD11b, CD14, and Toll-like receptors 2 and 4. Moreover, prophylactic administration of UPP was found to protect against body weight loss and lymphatic organ damage in cyclophosphamide-induced immunosuppressed mice. In addition, UPP demonstrated significant stimulatory effects on various immunocytes, such as T cells, B cells, macrophages, and natural killer cells derived from the spleen. These effects were closely related to the mitogen-activated protein kinase and nuclear factor-kappa B pathways, and significant secretion of immunostimulatory cytokines such as IL-6, -12, and TNF-α was noted in both blood and spleen samples. Impairment of the short-chain fatty acid balance in the cecum was prevented by UPP administration in a dose-dependent manner. Consequently, these results suggest that the UPP isolated from U. pertusa contributes to immune system activation.
Sujet(s)
Cyclophosphamide , Souris de lignée BALB C , Ulva , Animaux , Cyclophosphamide/pharmacologie , Souris , Ulva/composition chimique , Cytokines/métabolisme , Adjuvants immunologiques/pharmacologie , Polyosides/pharmacologie , Polyosides/composition chimique , Polyosides/isolement et purification , Mannanes/pharmacologie , Mannanes/composition chimique , Mannanes/isolement et purification , Phagocytose/effets des médicaments et des substances chimiques , Macrophages/effets des médicaments et des substances chimiques , Macrophages/immunologie , Macrophages/métabolisme , Facteur de transcription NF-kappa B/métabolisme , Rate/effets des médicaments et des substances chimiques , Rate/cytologie , Rate/immunologie , Cellules RAW 264.7 , Mitogen-Activated Protein Kinases/métabolisme , MâleRÉSUMÉ
Chronic pain has emerged as a significant public health issue, seriously affecting patients' quality of life and psychological well-being, with a lack of effective pharmacological treatments. Numerous studies have indicated that macrophages play a crucial role in inflammatory pain, and targeting neuro-immune interactions for drug development may represent a promising direction for pain management. Chilobrachys jingzhao (C. jingzhao) is used as a folk medicine of the Li nationality with the efficacy of eliminating swelling, detoxicating, and relieving pain, and the related products are widely used in the market. However, the chemical constituents of C. jingzhao have not been reported, and the pharmacodynamic substance and the precise functional mechanism are unrevealed. Here we isolated a cyclic dipeptide, cyclo(L-Pro-L-Trp) (CPT) from C. jingzhao for the first time. CPT remarkably alleviated formalin-induced inflammatory pain and significantly inhibited inflammatory responses. In vivo, CPT attenuated neutrophil infiltration and plantar tissue edema and suppressed the mRNA expression of pro-inflammatory molecules. In vitro, CPT suppressed inflammation triggered by lipopolysaccharide (LPS) in both RAW 264.7 and iBMDM cells, reducing expressions of inducible nitric oxide synthase (iNOS), superoxide, and pro-inflammatory molecules. A mechanistic study revealed that CPT exerted an anti-inflammatory activity by blocking the mitogen-activated protein kinases (MAPK) and nuclear factor-kappa B (NF-κB) signaling pathways, as well as alleviating the ubiquitination of tumor necrosis factor receptor-associated factor 6 (TRAF6). Our results elucidated the pharmacodynamic material basis of C. jingzhao, and CPT can be a promising lead for alleviating inflammation and inflammatory pain.
Sujet(s)
Anti-inflammatoires , Formaldéhyde , Inflammation , Facteur de transcription NF-kappa B , Transduction du signal , Facteur-6 associé aux récepteurs de TNF , Animaux , Facteur de transcription NF-kappa B/métabolisme , Souris , Facteur-6 associé aux récepteurs de TNF/métabolisme , Anti-inflammatoires/usage thérapeutique , Anti-inflammatoires/pharmacologie , Mâle , Transduction du signal/effets des médicaments et des substances chimiques , Inflammation/traitement médicamenteux , Cellules RAW 264.7 , Peptides cycliques/pharmacologie , Peptides cycliques/usage thérapeutique , Douleur/traitement médicamenteux , Douleur/induit chimiquement , Analgésiques/usage thérapeutique , Analgésiques/pharmacologie , Humains , Oedème/traitement médicamenteux , Oedème/induit chimiquement , Oedème/immunologie , Mitogen-Activated Protein Kinases/métabolisme , Macrophages/effets des médicaments et des substances chimiques , Macrophages/immunologieRÉSUMÉ
PURPOSE: To investigate esketamine's impact on inflammation and oxidative stress in ventilated chronic obstructive pulmonary disease (COPD) rats, examining its regulatory mechanisms. METHODS: Rats were divided into four groups: control group (Con), COPD model group (M), COPD model with saline treatment group (M+S), and COPD model with esketamine treatment group (M+K), with 12 rats in each group. After two months, all rats underwent anesthesia and mechanical ventilation. Group M+K received 5 mg/kg esketamine intravenously, while Group M+S received the same volume of saline. Lung tissues were collected for analysis two hours later, including airway peak pressure, wet-to-dry(W/D) ratio, lung permeability index(LPI), hematoxylin and eosin(H&E) staining, and transmission electron microscopy(TEM). Tumor necrosis factor-alpha(TNF-α), interleukin-6(IL-6), interleukin-8(IL-8), and interleukin-10(IL-10) levels were determined by enzyme-linked immunosorbent assay(ELISA); phosphorylated Nuclear Factor Kappa B(p-NF-κB), mitogen-activated protein kinase 14(p38), phosphorylated p38 (p-p38), c-Jun N-terminal kinase(JNK), and phosphorylated JNK (p-JNK) expressions by Western blotting and immunohistochemistry; and malondialdehyde(MDA), myeloperoxidase(MPO), and superoxide dismutase(SOD) levels were also measured by corresponding biochemical assays. RESULTS: Lung specimens from groups M, M+S, and M+K manifested hallmark histopathological features of COPD. Compared with group Con, group M displayed increased peak airway pressure, W/D ratio, and LPI. In group M+K, compared with group M, esketamine significantly reduced the W/D ratio, LPI, and concentrations of pro-inflammatory cytokines TNF-α, IL-6, and IL-8 while concurrently elevating IL-10 levels. Furthermore, the treatment attenuated the activation of the NF-κB and MAPK pathways, indicated by decreased levels of p-NF-κB, p-p38, and p-JNK.Additionally, compared to group M, group M+K showed decreased MDA and MPO levels and increased SOD levels in lung tissue. CONCLUSION: Esketamine attenuates mechanical ventilation-induced lung injury in COPD rat models by inhibiting the MAPK/NF-κB signaling pathway and reducing oxidative stress.
Sujet(s)
Cytokines , Kétamine , Poumon , Facteur de transcription NF-kappa B , Stress oxydatif , Broncho-pneumopathie chronique obstructive , Rat Sprague-Dawley , Transduction du signal , Animaux , Kétamine/usage thérapeutique , Kétamine/pharmacologie , Stress oxydatif/effets des médicaments et des substances chimiques , Facteur de transcription NF-kappa B/métabolisme , Broncho-pneumopathie chronique obstructive/traitement médicamenteux , Broncho-pneumopathie chronique obstructive/métabolisme , Mâle , Cytokines/métabolisme , Rats , Poumon/anatomopathologie , Poumon/effets des médicaments et des substances chimiques , Poumon/métabolisme , Poumon/immunologie , Transduction du signal/effets des médicaments et des substances chimiques , Lésion pulmonaire induite par la ventilation mécanique/traitement médicamenteux , Lésion pulmonaire induite par la ventilation mécanique/métabolisme , Lésion pulmonaire induite par la ventilation mécanique/anatomopathologie , Anti-inflammatoires/pharmacologie , Anti-inflammatoires/usage thérapeutique , Modèles animaux de maladie humaine , Ventilation artificielle/effets indésirables , Humains , Système de signalisation des MAP kinases/effets des médicaments et des substances chimiques , Mitogen-Activated Protein Kinases/métabolismeRÉSUMÉ
OBJECTIVE: To delve into the underlying mechanism of Salidroside (Sal) on the improvement of cognitive function in Parkinson's Disease (PD). METHODS: The experimental mice were divided into Control group, Model group [injected with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)], and Model+Sal (low concentration, high concentration) group. Mouse hippocampal tissues were extracted for RNA sequencing to obtain the core pathway and core gene. Mouse plasma was prepared and analyzed by LC-MS to obtain differential metabolites. In vitro experiments were verified by immunofluorescence and lentiviral transduction. RESULTS: ELISA signaled that Sal facilitated the reduction of neuronal damage and inflammatory reaction in mice. MPTP_Sal_Low and MPTP_Sal_High groups had high levels of glial cell derived neurotrophie factor (GDNF) expression. Differentially expressed genes (DEGs) in control group, MPTP group and MPTP_Sal_High group were identified by transcriptomic, which were classified to the mitogen-activated protein kinase (MAPK) signaling pathway, and the core gene Braf was obtained. Metabolomics manifested that the differential metabolites involved DL-tyrosine, adenosine, phosphoenolpyruvate, and L-tryptophan. In vitro experiments verified that Sal treatment inhibited the up-regulation of p-p38, p-c-Jun N-terminal kinase (JNK), and p-extracellular signal-regulated kinase (ERK) expression, and growth of neuronal protrusions. The OE-Braf group showed a significant up-regulation of the GDNF expression, a decrease in the expression of p-p38, p-JNK, and p-ERK, and a significant growth of neuronal protrusions. CONCLUSION: Sal may exert its effects in PD through the Braf-mediated MAPK signaling pathway, which can increase GDNF expression and promote neuronal protrusion growth for the protection of neurological function and the improvement of cognitive function.
Sujet(s)
Cognition , Facteur neurotrophique dérivé des cellules gliales , Glucosides , Système de signalisation des MAP kinases , Phénols , Protéines proto-oncogènes B-raf , Animaux , Mâle , Souris , Cognition/effets des médicaments et des substances chimiques , Modèles animaux de maladie humaine , Facteur neurotrophique dérivé des cellules gliales/métabolisme , Glucosides/pharmacologie , Hippocampe/effets des médicaments et des substances chimiques , Hippocampe/métabolisme , Système de signalisation des MAP kinases/effets des médicaments et des substances chimiques , Souris de lignée C57BL , Mitogen-Activated Protein Kinases/métabolisme , Neuroprotecteurs/pharmacologie , Maladie de Parkinson/traitement médicamenteux , Maladie de Parkinson/métabolisme , Phénols/pharmacologie , Protéines proto-oncogènes B-raf/génétique , Protéines proto-oncogènes B-raf/métabolisme , Transduction du signal/effets des médicaments et des substances chimiquesRÉSUMÉ
Smk1 is a MAPK homolog in the yeast Saccharomyces cerevisiae that controls the postmeiotic program of spore wall assembly. During this program, haploid cells are surrounded by a layer of mannan and then a layer of glucan. These inner layers of the spore wall resemble the vegetative cell wall. Next, the outer layers consisting of chitin/chitosan and then dityrosine are assembled. The outer layers are spore-specific and provide protection against environmental stressors. Smk1 is required for the proper assembly of spore walls. However, the protective properties of the outer layers have limited our understanding of how Smk1 controls this morphogenetic program. Mutants lacking the chitin deacetylases, Cda1 and Cda2, form spores that lack the outer layers of the spore wall. In this study, cda1,2∆ cells were used to demonstrate that Smk1 promotes deposition of the glucan layer of the spore wall through the partially redundant glucan synthases Gsc2 and Fks3. Although Gsc2 is localized to sites of spore wall assembly in the wild type, it is mislocalized in the mother cell cytoplasm in the smk1∆ mutant. These findings suggest that Smk1 controls assembly of the spore wall by regulating the localization of Gsc2 during sporogenesis.
Sujet(s)
Paroi cellulaire , Glucanes , Mitogen-Activated Protein Kinases , Protéines de Saccharomyces cerevisiae , Saccharomyces cerevisiae , Spores fongiques , Paroi cellulaire/métabolisme , Paroi cellulaire/génétique , Glucanes/métabolisme , Glucosyltransferases/génétique , Glucosyltransferases/métabolisme , Protéines membranaires , Mitogen-Activated Protein Kinases/métabolisme , Mitogen-Activated Protein Kinases/génétique , Saccharomyces cerevisiae/génétique , Saccharomyces cerevisiae/métabolisme , Saccharomyces cerevisiae/enzymologie , Protéines de Saccharomyces cerevisiae/génétique , Protéines de Saccharomyces cerevisiae/métabolisme , Spores fongiques/génétique , Spores fongiques/croissance et développement , Spores fongiques/métabolismeRÉSUMÉ
Preeclampsia (PE) is often associated with multiple organ damage that remains noticeable postnatally. Here, we tested the hypotheses that antenatal therapy with nonsteroidal antiinflammatory drugs (NSAIDs) refashions liver damage induced by PE in weaning rats and that the high mobility group box 1 (HMGB1) signaling modulates this interaction. PE was induced by pharmacologic nitric oxide deprivation during the last week of gestation (Nω-nitro-L-arginine methyl ester, L-NAME, 50 mg/kg/day, oral gavage). Compared with control rats, weaning PE rats revealed substantial rises in serum transaminases together with histopathological signs of hepatic cytoplasmic changes, portal inflammation, and central vein dilation. While gestational NSAIDs reversed the elevated transaminases, they had no effects (celecoxib, naproxen) or even worsened (diclofenac) the structural damage. Molecularly, celecoxib was the most effective NSAID in (i) reversing PE-evoked upregulation of hepatic HMGB1 gene expression and concomitant increments and decrements in mitogen-activated protein kinases MAPKERK and MAPKp38 expression, respectively, and (ii) elevating and suppressing serum interleukin-10 and tumor necrosis factor-α, respectively. Alternatively, rises in serum interleukin-1ß and shifts in macrophage polarization towards an inflammatory phenotype caused by PE were comparably diminished by all NSAIDs. The data disclose an advantageous therapeutic potential for gestational celecoxib over diclofenac or naproxen in controlling hepatic dysfunction and HMGB1-interrelated inflammatory and oxidative sequels of PE.
Sujet(s)
Célécoxib , Protéine HMGB1 , Foie , Pré-éclampsie , Animaux , Grossesse , Femelle , Protéine HMGB1/métabolisme , Célécoxib/pharmacologie , Célécoxib/usage thérapeutique , Pré-éclampsie/traitement médicamenteux , Rats , Foie/effets des médicaments et des substances chimiques , Foie/métabolisme , Foie/anatomopathologie , Système de signalisation des MAP kinases/effets des médicaments et des substances chimiques , Anti-inflammatoires non stéroïdiens/pharmacologie , Anti-inflammatoires non stéroïdiens/usage thérapeutique , Rat Wistar , Transduction du signal/effets des médicaments et des substances chimiques , Mitogen-Activated Protein Kinases/métabolismeRÉSUMÉ
Signal transduction proteins containing a pLxIS motif induce interferon (IFN) responses central to antiviral immunity. Apart from their established roles in activating the IFN regulator factor (IRF) transcription factors, the existence of additional pathways and functions associated with the pLxIS motif is unknown. Using a synthetic biology-based platform, we identified two orphan pLxIS-containing proteins that stimulate IFN responses independent of all known pattern-recognition receptor pathways. We further uncovered a diversity of pLxIS signaling mechanisms, where the pLxIS motif represents one component of a multi-motif signaling entity, which has variable functions in activating IRF3, the TRAF6 ubiquitin ligase, IκB kinases, mitogen-activated protein kinases, and metabolic activities. The most diverse pLxIS signaling mechanisms were associated with the highest antiviral activities in human cells. The flexibility of domains that regulate IFN signaling may explain their prevalence in nature.
Sujet(s)
Facteur-3 de régulation d'interféron , Interférons , Transduction du signal , Facteur-6 associé aux récepteurs de TNF , Humains , Interférons/métabolisme , Cellules HEK293 , Facteur-3 de régulation d'interféron/métabolisme , Facteur-3 de régulation d'interféron/génétique , Facteur-6 associé aux récepteurs de TNF/métabolisme , Facteur-6 associé aux récepteurs de TNF/génétique , I-kappa B Kinase/métabolisme , I-kappa B Kinase/génétique , Domaines protéiques , Animaux , Protéines et peptides de signalisation intracellulaire/métabolisme , Protéines et peptides de signalisation intracellulaire/génétique , Motifs d'acides aminés , Mitogen-Activated Protein Kinases/métabolismeRÉSUMÉ
Replicative senescence is triggered when telomeres reach critically short length and activate permanent DNA damage checkpoint-dependent cell cycle arrest. Mitochondrial dysfunction and increase in oxidative stress are both features of replicative senescence in mammalian cells. However, how reactive oxygen species levels are controlled during senescence is elusive. Here, we show that reactive oxygen species levels increase in the telomerase-negative cells of Saccharomyces cerevisiae during replicative senescence, and that this coincides with the activation of Hog1, a mammalian p38 MAPK ortholog. Hog1 counteracts increased ROS levels during replicative senescence. While Hog1 deletion accelerates replicative senescence, we found this could stem from a reduced cell viability prior to telomerase inactivation. ROS levels also increase upon telomerase inactivation when Mec1, the yeast ortholog of ATR, is mutated, suggesting that oxidative stress is not simply a consequence of DNA damage checkpoint activation in budding yeast. We speculate that oxidative stress is a conserved hallmark of telomerase-negative eukaryote cells, and that its sources and consequences can be dissected in S. cerevisiae.
Sujet(s)
Protéines et peptides de signalisation intracellulaire , Mitogen-Activated Protein Kinases , Stress oxydatif , Protein-Serine-Threonine Kinases , Espèces réactives de l'oxygène , Protéines de Saccharomyces cerevisiae , Saccharomyces cerevisiae , Telomerase , Saccharomyces cerevisiae/génétique , Saccharomyces cerevisiae/métabolisme , Protéines de Saccharomyces cerevisiae/métabolisme , Protéines de Saccharomyces cerevisiae/génétique , Telomerase/métabolisme , Telomerase/génétique , Espèces réactives de l'oxygène/métabolisme , Mitogen-Activated Protein Kinases/métabolisme , Mitogen-Activated Protein Kinases/génétique , Protéines et peptides de signalisation intracellulaire/métabolisme , Protéines et peptides de signalisation intracellulaire/génétique , Protein-Serine-Threonine Kinases/métabolisme , Protein-Serine-Threonine Kinases/génétique , Altération de l'ADNRÉSUMÉ
RASopathies are rare developmental genetic syndromes caused by germline pathogenic variants in genes that encode components of the RAS/mitogen-activated protein kinase (MAPK) signal transduction pathway. Although the incidence of each RASopathy syndrome is rare, collectively, they represent one of the largest groups of multiple congenital anomaly syndromes and have severe developmental consequences. Here, we review our understanding of how RAS/MAPK dysregulation in RASopathies impacts skeletal muscle development and the importance of RAS/MAPK pathway regulation for embryonic myogenesis. We also discuss the complex interactions of this pathway with other intracellular signaling pathways in the regulation of skeletal muscle development and growth, and the opportunities that RASopathy animal models provide for exploring the use of pathway inhibitors, typically used for cancer treatment, to correct the unique skeletal myopathy caused by the dysregulation of this pathway.
Sujet(s)
Développement musculaire , Muscles squelettiques , Protéines G ras , Humains , Animaux , Muscles squelettiques/métabolisme , Muscles squelettiques/anatomopathologie , Protéines G ras/métabolisme , Développement musculaire/génétique , Transduction du signal , Système de signalisation des MAP kinases , Mitogen-Activated Protein Kinases/métabolisme , Modèles animaux de maladie humaineRÉSUMÉ
Intrinsic and acquired resistance to mitogen-activated protein kinase inhibitors (MAPKi) in melanoma remains a major therapeutic challenge. Here, we show that the clinical development of resistance to MAPKi is associated with reduced tumor expression of the melanoma suppressor Autophagy and Beclin 1 Regulator 1 (AMBRA1) and that lower expression levels of AMBRA1 predict a poor response to MAPKi treatment. Functional analyses show that loss of AMBRA1 induces phenotype switching and orchestrates an extracellular signal-regulated kinase (ERK)-independent resistance mechanism by activating focal adhesion kinase 1 (FAK1). In both in vitro and in vivo settings, melanomas with low AMBRA1 expression exhibit intrinsic resistance to MAPKi therapy but higher sensitivity to FAK1 inhibition. Finally, we show that the rapid development of resistance in initially MAPKi-sensitive melanomas can be attributed to preexisting subclones characterized by low AMBRA1 expression and that cotreatment with MAPKi and FAK1 inhibitors (FAKi) effectively prevents the development of resistance in these tumors. In summary, our findings underscore the value of AMBRA1 expression for predicting melanoma response to MAPKi and supporting the therapeutic efficacy of FAKi to overcome MAPKi-induced resistance.